The U.S. Food and Drug Administration announced that new safety information has been added to the label for the HIV antiviral drug Invirase (saquinavir). The warning describes potentially life-threatening cardiovascular side effects the drug is used with Norvir (ritonavir). Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230442.htm.
New safety information for Invirase
*Online Bonus Content: This has not been peer reviewed. The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal.
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
Take this 4-question survey to be entered to win an Visa $50 gift card.
*Winner of the gift card will be drawn on December 31st, 2024. The winner will be contacted by email. By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address, may be used to keep you informed about future products and services.
